Work Description - Request For Expression Of Interest (reoi) For Development Of A Novel Monoclonal Antibody Cell Line Development For Investigational New Drug

The Department of Biotechnology, Translational Health Science and Technology Institute (THSTI), Faridabad, invites Expressions of Interest (EOI) for the development of a novel monoclonal antibody cell line for Investigational New Drug purposes (Tender ID: 2024_MST_774258_1; Reference Number: THSTI/S and P/REOI/01/024-25). This EOI, with a tender value of ₹2,00,00,000, requires the development of a novel monoclonal antibody cell line. The EOI documents are available for download from October 7th, 2024, 4:15 PM to October 28th, 2024, 11:00 AM. Submissions are due by October 28th, 2024, 11:00 AM, with bid opening scheduled for 11:30 AM the same day at THSTI, Faridabad. No tender fee or earnest money deposit (EMD) is required. A pre-bid meeting will be held on October 14th, 2024, at 11:00 AM at THSTI, Faridabad. The contract period is 30 days, and the bid validity is 120 days. Interested parties should refer to the tender documents for details regarding NDA/Pre-qualification.